← Evidence map

ArticleIntegrative cancer therapies

Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway.

Wenbo Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2023
2024
2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 35234063